NoteworthyProgenitor's move with leptin

Progenitor Inc. on Friday announced the publication of its International Patent application (WO 96/08510) covering the receptor for leptin. The application also covers the gene for the receptor, expression vectors and genetically engineered cells carrying the gene.

Investors anxious to play the on-going developments in the race to develop applications of leptin, the so-called obesity gene, quickly bid up shares of Progenitor's parent, Interneuron Pharmaceuticals Inc. (IPIC, Lexington, Mass.), which gained $4 on the day to close at $35.50 on 1.6 million shares traded.